Skip to content

A study to evaluate the effect of decreasing postprandial glucose levels of functional food

A study to evaluate the effect of decreasing postprandial glucose levels of functional food - A study to evaluate the effect of decreasing postprandial glucose levels of functional food

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030847
Enrollment
20
Registered
2018-01-24
Start date
2018-01-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Subjects will take the test food once a day. After more than 1 day of washout period, subjects will take the placebo food once a day. Subjects will take the placebo food once a day. After more than 1

Sponsors

Suntory Global Innovation Center Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Males and females over 20 years old 2. Understanding the study and submitting the written informed consent before the study

Exclusion criteria

Exclusion criteria: 1. Systolic pressure <90 mmHg 2. Subjects who are pregnant or lactating. 3. Subjects who donated over 200ml blood components or whole blood within 4 weeks 4. Male Subjects who donated over 400ml whole blood within 12 weeks 5. Female who donated over 400ml whole blood within 16 weeks 6. Male subjects whose blood was collected more than 1200 mL within the last twelve months when the amount of blood sampling in the current study is added. 7. Female subjects whose blood was collected more than 800 mL within the last twelve months when the amount of blood sampling in the current study is added. 8. Subjects who are participating in other clinical studies, or who finished clinical study within 4 weeks. 9. a) Subjects with disease on heart, liver, kidney or other organs complication. b) Subjects with a previous history of disease on circulatory organs c) Subjects who are contracting diabetes. d) Subjects with test food allergy 10. Subjects who are judged as unsuitable for the study by the principal investigator for other reasons.

Design outcomes

Primary

MeasureTime frame
Efficacy : Area under the curve of delta blood glucose level. Safety : Incidence of adverse events

Countries

Japan

Contacts

Public ContactKeisuke Yasumoto

Suntory Global Innovation Center Ltd. Research Institute

Keisuke_Yasumoto@suntory.co.jp050-3182-0496

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026